Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Not Yet Recruiting

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

NCT06290765

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Significance of Leukocyte Cell Population Data in Patients With Myeloproliferative Neoplasms (MPNs)

NCT06753279

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.

NCT06647706

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms

NCT06334913

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

NCT06022341

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

NCT04451200

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

NCT03480360

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +33 more
Locations: Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

NCT05177211

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Neutrophilic Leukemia, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

UCLA Medical Center Los Angeles, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States

View all 48 locations

View Trial Details

Completed

A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms

NCT04339400

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: West China Hospital ,Sichuan University Chengdu, Sichuan, China

Hematology Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions